Xizhi Zhang

Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial

Zixian Wang, Chengxu Cui, Jun Yao et al. · Cancer Cell · 2022 · 523 citations · Full text

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8

Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study

Zhi Peng, Tianshu Liu, Jia Wei et al. · Cancer Communications · 2021 · 182 citations · Full text

Effective PEGylation of Iron Oxide Nanoparticles for High Performance In Vivo Cancer Imaging

Dongfang Liu, Wei Wu, Jingjing Ling et al. · Advanced Functional Materials · 2011 · 135 citations

Nanoparticles, Nanotherapeutics, Engineering +19

miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer

Yong Chen, Lingfeng Min, Chuanli Ren et al. · PLoS ONE · 2017 · 108 citations · Full text

Oncology, Prognostic Factor, Medicine +15